Navigation Links
Mexico's expanded health insurance improves hypertension treatment
Date:11/7/2007

Mexicos new health insurance program, Seguro Popular, which was created to extend health insurance to the nations 50 million uninsured by 2010, is having a positive effect on coverage of antihypertensive treatment in that country, according to a study published in the October 27 issue of British Medical Journal. Results of the study show that adults insured through Seguro Popular are significantly more likely to receive treatment for hypertension and significantly more likely to have their blood pressure controlled than those without health insurance.

Lack of health insurance has been consistently identified as a key obstacle to hypertension treatment and Mexico is among the last of the OECD countries to guarantee health insurance for all of its citizens, said Sara N. Bleich, PhD, lead author of the study and assistant professor in the Johns Hopkins Bloomberg School of Public Healths Department of Health Policy and Management. Bleich conducted the research while completing her doctoral degree at Harvard University. The odds of receiving antihypertensive treatment were 50 percent higher for those insured through Seguro Popular than those without insurance.

The study also showed that those insured through the program had a 35-percent-higher odds of receiving treatment with blood pressure control compared to the uninsured. In addition, the impact of Seguro Popular was greatest in regions of Mexico where there were higher concentrations of health care providers.

According to Bleich, hypertension affects more than 9 million adults in Mexico. It is a risk factor for cardiovascular disease and stroke, which are among the leading causes of death in Mexico. Treatment of the disease will cost Mexico an estimated $3 billion this year.

For the study, the researchers examined national health data from 1,065 uninsured adults and compared them to an equal number of adults covered through Seguro Popular. The participants were selected from a
'/>"/>

Contact: Tim Parsons
paffairs@jhsph.edu
410-955-6878
Johns Hopkins University Bloomberg School of Public Health
Source:Eurekalert

1

GOOD

Page: 1 2

Related medicine news :

1. FDA Approves Expanded Label for FluMist(R) to Include Children Two to Five Years of Age
2. FDA approves expanded label for FluMist (influenza virus vaccine live, intranasal) to include childr
3. FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia
4. Eularis Announces New Corporate Name and Expanded Product Offerings
5. E. Coli Registry Expanded for Victims of E. Coli Poisoning from Cargill Ground Beef
6. AMDL Launches Expanded Distribution With 4th Round of Agreements Valued at $6.79 Million Annually for New Health & Beauty Product Line
7. Penn study finds pro-death proteins required to regulate healthy immune function
8. UCLA researchers identify markers that may predict diabetes in still-healthy people
9. Air pollution linked to cardiovascular risk indices in healthy young adults
10. More proof needed of safety and quality of electronic personal health records
11. Health care incentive model offers collaborative approach
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)...D, Calif., Jan. 8 (Nas...") announced today that it has submitted an Invest...the US Food and Drug Administration ("FDA" or the ...") study of the Levacor(TM) Ventricular Assist Dev... detailed device information, including design and...
(Date:1/8/2009)...RK, Jan. 8 We hear it everywhere: ... is a carbon footprint, and how can you reduce y...akes is a little thought and planning to bring it ...YSE: SI ) at: http://media.medialink.com/WebNR....n access video, audio, text, graphics and photos f...
(Date:1/8/2009)... Yet another reason to use a tread... Phoenix, AZ (PRWEB) Januar...ff by the medical community warning of America,s r... to disease. The National Cancer Institute complet...ant relationship between excess weight gain and ov...
(Date:1/8/2009)... has been one of the most amazing recovery cases I...Michael Kronenberger, MD, Otolaryngology, Dallas, ...he span of four years, Wally Hogland suffered a st... advanced stage IV cancer. , , "When my doctor ...nd, tears welling up in his eyes at the painful re...
Breaking Medicine News(10 mins):Health News:WorldHeart Submits IDE Application for a Pivotal Bridge-to-Transplant Study of the Levacor(TM) VAD 2Health News:Treadmill Desks Combat Obesity Linked to Higher Rates of Ovarian Cancer 2Health News:Treadmill Desks Combat Obesity Linked to Higher Rates of Ovarian Cancer 3Health News:One Man's Determined Journey to Remission and a Renewed Sense of Faith 2
...vestigating the mysterious death of a woman whose ...ood oozed from her ears in an ordeal that started ...Reeling from shock and disbelief, the family of Ju...nswers. Officials have classified the case as an u...
...ature that we want to know answers to everything. ... our own self. How often have we questioned the d...e answers just do not come. Researchers in a break...ystery surrounding heart failure. They found that ...
...ings of a recent study researchers say Cocoa flav...ave an impact on the brain. Cocoa flavonols were f...ain. In a study on 16 healthy young women, resear...g cognitive tasks using functional MRI. The partic...
...ly 27 : Identifying a key gene that controls speci...nding of neurological disorders and lead to better...a to multiple sclerosis, researchers said Wednesda...re (NUS) study has unveiled a new gene that speeds...
Other Medicine News:
(Date:1/6/2009)... -- Pacira Pharmaceuticals, Inc., an,acute care s...hat enrollment,has been completed in two pivotal ...d efficacy of a single intraoperative administrati... postoperative analgesia. , Results from th...rthroplasty (TKA) are expected to provide the prim...
(Date:1/5/2009)... -- Women undergoing in vitro,fertilization (IVF)...arly,pregnancy, but the intramuscular injections ...for patients. Formulations of progesterone medica...jection or vaginal suppository may offer,similar ...th patient well-being a constant focus, Fertility ...
(Date:12/27/2008)...-FirstCall/ -- Warner Chilcott Limited (Nasdaq: ...s and Mayne Pharma International Pty. Ltd. ("Mayne...uits against each of Mutual Pharmaceutical Company...lan") and Impax Laboratories, Inc. ("Impax") in t...or infringement of Mayne,s U.S. Patent No. 6,958,1...
(Date:12/17/2008)...hat normal stem cells can act as the source of tum...nn., Dec. 17 /PRNewswire-USNewswire/ -- Scientis...nswered a central question in cancer biology: whet...m cells are immature cells that can renew themselv...at compose the range of body tissues. In recent ye...
Breaking Medicine Technology:Phase III Studies of EXPAREL(TM) (DepoBupivacaine) from Pacira Complete Enrollment 2Phase III Studies of EXPAREL(TM) (DepoBupivacaine) from Pacira Complete Enrollment 3Fertility Physicians of Northern California Researchers Test New Forms of Progesterone Medication for Luteal Support During IVF 2Warner Chilcott Files Lawsuits for Infringement of DORYX(R) Patent 2Warner Chilcott Files Lawsuits for Infringement of DORYX(R) Patent 3Molecular Marker Identifies Normal Stem Cells as Intestinal Tumor Source 2Molecular Marker Identifies Normal Stem Cells as Intestinal Tumor Source 3New Data From Phase 3 Study Suggests Tapentadol Immediate Release Effective for Acute Pain From Common Foot Surgery 2025 1New Data From Phase 3 Study Suggests Tapentadol Immediate Release Effective for Acute Pain From Common Foot Surgery 2025 2New Data From Phase 3 Study Suggests Tapentadol Immediate Release Effective for Acute Pain From Common Foot Surgery 2025 3New Data From Phase 3 Study Suggests Tapentadol Immediate Release Effective for Acute Pain From Common Foot Surgery 2025 4New Data From Phase 3 Study Suggests Tapentadol Immediate Release Effective for Acute Pain From Common Foot Surgery 2025 5Training Student Leaders Cuts Peers Smoking Rates 18940 1Training Student Leaders Cuts Peers Smoking Rates 18940 2Health researchers in McGill network receive 2435 5 million in CIHR funding 18937 1Health researchers in McGill network receive 2435 5 million in CIHR funding 18937 2Health researchers in McGill network receive 2435 5 million in CIHR funding 18937 3Passport Health Disaster Response Experts Offer Services to Myanmar Volunteers 18934 1Passport Health Disaster Response Experts Offer Services to Myanmar Volunteers 18934 2
...TTSDALE, Ariz.--(BUSINESS WIRE)--Jun 27, 2007 - An...s of a two-year clinical,study on the impact of ge...hytoestrogen Genistein on Bone Metabolism in Osteo...pears in the current,issue (June 19, 2007) and det...dietary management of osteopenia and,osteoporosis....
...tement by Sandra C. Raymond, President & CEO o...N, June 27, 2007 /PRNewswire-USNewswire/ -- The Lu...million Americans,with lupus have been awaiting th...rials for CellCept(R), a potential treatment for,l...ceutical,Company. Development of new treatments fo...
Other Medicine Technology:New Proof of Genistein's Efficacy and Safety for Osteopenia and,Osteoporosis Published in Annals of Internal Medicine 2New Proof of Genistein's Efficacy and Safety for Osteopenia and,Osteoporosis Published in Annals of Internal Medicine 3Lupus Foundation of America Statement on Results for Clinical Study,of CellCept Released by Aspreva Pharmaceutical Company 2
...las D Fibertom is a 60 watt diode continuous wave ...ower Bar technology and 940 nm wavelength make thi...tment for varicose veins and a variety of surgical...s unique safety features including the LPS, Light ...
Roths 28 Hue test studies the characteristic axies of dyschromatopsia similar to the Farnsworth D15, however this 28 hue test provides a greater degree of sensitivity. Case comes with a transparent
...sc test for detecting and grading acquired color d...ive estimation of saturation thresholds for bluish...for differences between normal and acquired vision...tic plates, discriminates between congenital and a...
Gas powered, single use, reloadable, laparoscopic 15 mm linear cutting stapler for resection, transection and anastomosis with titanium staples.
Medicine Products: